Increased wall tension in response to vasoconstrictors in isolated mesenteric arterial rings from patients with high blood pressure

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 6, 2006, Pages 440-449

  Tahvanainen, Anna ^a   Taurio, Jyrki ^b   Mäki Jouppi, Jenni ^a   Kööbi, Peeter ^a   Mustonen, Jukka ^a,b   Kähönen, Mika ^b   Sand, Juhani ^b   Nordback, Isto ^b   Pörsti, Ilkka ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIMYCIN; CALCIUM CHANNEL BLOCKING AGENT; DICLOFENAC; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; N(G) NITROARGININE METHYL ESTER; NIFEDIPINE; NITRATE; NITROPRUSSIDE SODIUM; NORADRENALIN; POTASSIUM CHLORIDE; SEROTONIN; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTERY DIAMETER; ARTERY WALL; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; MESENTERIC ARTERY; PRIORITY JOURNAL; VASCULAR RING; VASOCONSTRICTION;

ADULT; AGED; AGED, 80 AND OVER; DICLOFENAC; FEMALE; HUMANS; HYPERTENSION; MALE; MESENTERIC ARTERIES; MIDDLE AGED; NG-NITROARGININE METHYL ESTER; NIFEDIPINE; NOREPINEPHRINE; POTASSIUM CHLORIDE; SEROTONIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

ANIMALIA;

EID: 33751374610     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_572.x     Document Type: Article

References (34)

1. Aalkjær, C., H. Eiskjær, M. J. Mulvany, B. Jespersen, T. Kjær, S. S. Sørensen & E. B. Pedersen: Abnormal structure and function of isolated subcutaneous resistance vessels from essential hypertensive patients despite antihypertensive treatment. J. Hypertens. 1989, 7, 305-310.
2. Aalkjær, C., A. M. Heagerty, K. K. Petersen, J. D. Swales & M. J. Mulvany: Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ. Res. 1987, 61, 181-186.
3. Alam, T. A., A. M. Seifalian & D. Baker: A review of methods currently used for assessment of in vivo endothelial function. Eur. J. Vasc. Endovasc. Surg. 2005, 29, 269-276.
4. Angus, J. A.: Role of the endothelium in the genesis of cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 1996, 23, S16-S22.
5. Blacher, J., M. E. Safar, B. Pannier, A. P. Guerin, S. J. Marchais & G. M. London: Prognostic significance of arterial stiffness measurements in end-stage renal disease patients. Curr. Opin. Nephrol. Hypertens. 2002, 11, 629-634.
6. Charkoudian, N.: Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clin. Proc. 2003, 78, 603-612.
7. Falloon, B. J. & A. M. Heagerty: In vitro perfusion studies of human resistance artery function in essential hypertension. Hypertension 1994, 24, 16-23.
8. Granger, D. N., P. D. Richardson, P. R. Kvietys & N. A. Mortillaro: Intestinal blood flow. Gastroenterology 1980, 78, 837-863.
9. Guazzi, M., L. Lenatti, G. Tumminello & M. D. Guazzi: Effects of orthostatic stress on forearm endothelial function in normal subjects and in patients with hypertension, diabetes, or both diseases. Amer. J. Hypertens. 2005, 18, 986-994.
10. Hadoke, P. W., C. A. McIntyre, G. A. Gray & C. H. Buckley: Functional heterogeneity of large and small resistance arteries isolated from biopsies of subcutaneous fat: implications for investigation of vascular pathophysiology. Gen. Pharmacol. 2000, 35, 119-127.
11. Heagerty, A. M., C. Aalkjær, S. J. Bund, N. Korsgaard & M. J. Mulvany: Small artery structure in hypertension. Dual processes of remodeling and growth. Hypertension 1993, 21, 391-397.
12. Hutri-Kähönen, N., M. Kähönen, P. Jolma, X. Wu, J. Sand, I. Nordback, P. Ylitalo, P. Arvola & I. Pörsti: Control of mesenteric arterial tone in vitro in humans and rats. Naunyn Schmiedebergs Arch. Pharmacol. 1999a, 359, 322-330.
13. Hutri-Kähönen, N., M. Kähönen, X. Wu, J. Sand, I. Nordback, J. Taurio & I. Pörsti: Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients. Brit. J. Pharmacol. 1999b, 127, 1735-1743.
14. Intengan, H. D., L. Y. Deng, J. S. Li & E. L. Schiffrin: Mechanics and Composition of Human Subcutaneous Resistance Arteries in Essential Hypertension. Hypertension 1999, 33, 569-574.
15. Izzard, A. S. & A. M. Heagerty: Impaired flow-dependent dilatation in distal mesenteric arteries from the spontaneously hypertensive rat. J. Physiol. 1999, 518 (Pt 1), 239-245.
16. Klingbeil, A. U., S. John, M. P. Schneider, J. Jacobi, R. Handrock & R. E. Schmieder: Effect of AT1 receptor blockade on endothelial function in essential hypertension. Amer. J. Hypertens. 2003, 16, 123-128.
17. Kööbi, P., J. Kalliovalkama, P. Jolma, J. Rysä, H. Ruskoaho, O. Vuolteenaho, M. Kähönen, I. Tikkanen, M. Fan, P. Ylitalo & I. Pörsti: AT1 receptor blockade improves vasorelaxation in experimental renal failure. Hypertension 2003, 41, 1364-1371.
18. Madsen, J. L., S. B. Søndergaard & S. Møller: Meal-induced changes in splanchnic blood flow and oxygen uptake in middle-aged healthy humans. Scand. J. Gastroenterol. 2006, 41, 87-92.
19. Malik, R. A., I. J. Schofield, A. Izzard, C. Austin, G. Bermann & A. M. Heagerty: Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. Hypertension 2005, 45, 264-269.
20. Matheson, P. J., M. A. Wilson & R. N. Garrison: Regulation of intestinal blood flow. J. Surg. Res. 2000, 93, 182-196.
21. Meigs, J. B., J. O'Donnell C, G. H. Tofler, E. J. Benjamin, C. S. Fox, I. Lipinska, D. M. Nathan, L. M. Sullivan, R. B. D'Agostino & P. W. Wilson: Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the framingham offspring study. Diabetes 2006, 55, 530-537.
22. Mulvany, M. J.: Small artery remodeling in hypertension. Curr. Hypertens. Rep. 2002, 4, 49-55.
23. Oldenburg, W. A., L. L. Lau, T. J. Rodenberg, H. J. Edmonds & C. D. Burger: Acute mesenteric ischemia: a clinical review. Arch. Intern. Med. 2004, 164, 1054-1062.
24. Olsen, M. H., K. Wachtell, C. Aalkjær, R. B. Devereux, H. Dige-Petersen & H. Ibsen: Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension. Amer. J. Hypertens. 2001, 14, 861-867.
25. Onaka, U., K. Fujii, I. Abe & M. Fujishima: Antihypertensive treatment improves endothelium-dependent hyperpolarization in the mesenteric artery of spontaneously hypertensive rats. Circulation 1998, 98, 175-182.
26. Paniagua, O. A., M. B. Bryant & J. A. Panza: Role of endothelial nitric oxide in shear stress-induced vasodilation of human microvasculature: diminished activity in hypertensive and hypercholesterolemic patients. Circulation 2001, 103, 1752-1758.
27. Renwick, A. G., D. R. Robertson, B. Macklin, V. Challenor, D. G. Waller & C. F. George: The pharmacokinetics of oral nifedipine - a population study. Brit. J. Clin. Pharmacol. 1988, 25, 701-708.
28. Rizzoni, D., E. Porteri, D. Guefi, A. Piccoli, M. Castellano, G. Pasini, M. L. Muiesan, M. J. Mulvany & E. A. Rosei: Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000, 35, 931-935.
29. Salmasi, A. M. & M. Dancy: Glucose intolerance: the hidden danger in hypertensives! Int. Angiol. 2005, 24, 207-214.
30. Schiffrin, E. L.: Effect of antihypertensive treatment on small artery remodeling in hypertension. Can. J. Physiol. Pharmacol. 2003, 81, 168-176.
31. Schiffrin, E. L., Q. Pu & J. B. Park: Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Amer. J. Hypertens. 2002, 15, 105-110.
32. Schofield, I., R. Malik, A. Izzard, C. Austin & A. Heagerty: Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 2002, 106, 3037-3043.
33. Thybo, N. K., N. Stephens, A. Cooper, C. Aalkjær, A. M. Heagerty & M. J. Mulvany: Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension. Hypertension 1995, 25, 474-481.
34. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J. Hypertens. 1999, 17, 151-183.